Updated:
Crown Bioscience
Crown Bioscience is a contract research organization specializing in preclinical oncology and immuno-oncology models for biotech and pharma companies globally.
Crown Bioscience
Advance translational oncology with Crown Bioscience, a full-service CRO delivering comprehensive preclinical and oncology CRO services worldwide.
General information
Firm type
other
Location
Region
North America
Country
United States
City
Santa Clara
Corporate office
Santa Clara, CA, United States
Additional offices
San Diego, CA, United States · Frederick, MD, United States · Kannapolis, NC, United States · Osgathorpe, Loughborough, United Kingdom · Leiden, Netherlands · Hamburg, Germany · Beijing, China · Shanghai, China · Suzhou, China · Taicang, China · Tokyo, Japan · Suwon, South Korea · Hyderabad, India · Singapore
Sector focus
Frequently asked questions
Which services does Crown Bioscience provide?
Crown Bioscience is a CRO offering translational oncology and immuno-oncology services, including preclinical models such as PDX, CDX, syngeneic models, GEMM, humanized mouse models, and organoid cultures. They also provide histopathology, genomics, and IC50 data services (per the firm's website).
What types of preclinical models does Crown Bioscience offer?
The firm offers over 600 PDX organoid models, over 1000 cancer cell lines, over 200 CDX models, and over 100 syngeneic and GEMM models. Models include in vitro and in vivo preparations, with some derived from HUB organoid protocols (per the firm's website).
Where are Crown Bioscience's facilities located?
Crown Bioscience has laboratory and office locations in San Diego, Frederick, and Kannapolis in the US; Loughborough in the UK; Leiden in the Netherlands; Hamburg in Germany; Beijing, Shanghai, Suzhou, and Taicang in China; Tokyo, Suwon, Hyderabad, and Singapore (per the firm's website).
How does Crown Bioscience support regulatory changes in animal testing?
The company references the FDA Modernization Act 2.0 and notes the FDA's planned phase-out of animal testing requirements for certain therapies. It positions its human-relevant in vitro models as alternatives to animal studies (per the firm's website).
Is Crown Bioscience a single family office or an asset manager?
No. Crown Bioscience is a contract research organization (CRO) — a scientific services company, not a family office or asset manager. It was not possible to confirm any investment or ownership structure from available primary sources.
Who are the primary decision-makers or owners at Crown Bioscience?
The available primary sources, including the firm's website, do not name any senior executives, board members, or owners. This information was not found in the consulted sources.
Does Crown Bioscience have a known AUM or investment portfolio?
No. Crown Bioscience does not report AUM, investment assets, or capital deployment. It is a CRO providing services, not an investment firm. The AUM band display is 'Undisclosed.'
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on investors?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: